questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Manifestations neuromusculaires
Manifestations neuromusculaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Myopathies
Biopsie musculaire
Neuropathies
Électromyographie
Tests génétiques
Maladies héréditaires
Force musculaire
Évaluation clinique
Imagerie par résonance magnétique
Anomalies musculaires
Symptômes
5
Dystrophies musculaires
Faiblesse musculaire
Neuropathies périphériques
Douleur neuropathique
Myasthénie
Fatigue musculaire
Sclérose latérale amyotrophique
Difficultés de déglutition
Syndrome de Guillain-Barré
Faiblesse musculaire
Prévention
5
Neuropathies
Prévention des maladies
Crampes musculaires
Hydratation
Myopathies
Diagnostic précoce
Blessures musculaires
Échauffement
Sclérose latérale amyotrophique
Prévention
Traitements
5
Myopathies
Corticostéroïdes
Neuropathies diabétiques
Contrôle glycémique
Myasthénie
Inhibiteurs de l'acétylcholinestérase
Sclérose latérale amyotrophique
Soins palliatifs
Syndrome de Guillain-Barré
Immunoglobulines
Complications
5
Myopathies
Complications respiratoires
Neuropathies
Infections cutanées
Myasthénie
Crises myasthéniques
Sclérose latérale amyotrophique
Paralysie
Syndrome de Guillain-Barré
Complications neurologiques
Facteurs de risque
5
Myopathies
Antécédents familiaux
Neuropathies diabétiques
Diabète
Myasthénie
Maladies auto-immunes
Sclérose latérale amyotrophique
Âge avancé
Syndrome de Guillain-Barré
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Manifestations neuromusculaires : Questions médicales les plus fréquentes",
"headline": "Manifestations neuromusculaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Manifestations neuromusculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-13",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Manifestations neuromusculaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Manifestations neurologiques",
"url": "https://questionsmedicales.fr/mesh/D009461",
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neurologiques",
"code": {
"@type": "MedicalCode",
"code": "D009461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fasciculation",
"alternateName": "Fasciculation",
"url": "https://questionsmedicales.fr/mesh/D005207",
"about": {
"@type": "MedicalCondition",
"name": "Fasciculation",
"code": {
"@type": "MedicalCode",
"code": "D005207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Crampe musculaire",
"alternateName": "Muscle Cramp",
"url": "https://questionsmedicales.fr/mesh/D009120",
"about": {
"@type": "MedicalCondition",
"name": "Crampe musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypertonie musculaire",
"alternateName": "Muscle Hypertonia",
"url": "https://questionsmedicales.fr/mesh/D009122",
"about": {
"@type": "MedicalCondition",
"name": "Hypertonie musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Raideur musculaire",
"alternateName": "Muscle Rigidity",
"url": "https://questionsmedicales.fr/mesh/D009127",
"about": {
"@type": "MedicalCondition",
"name": "Raideur musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009127",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Spasticité musculaire",
"alternateName": "Muscle Spasticity",
"url": "https://questionsmedicales.fr/mesh/D009128",
"about": {
"@type": "MedicalCondition",
"name": "Spasticité musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009128",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.550.550"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypotonie musculaire",
"alternateName": "Muscle Hypotonia",
"url": "https://questionsmedicales.fr/mesh/D009123",
"about": {
"@type": "MedicalCondition",
"name": "Hypotonie musculaire",
"code": {
"@type": "MedicalCode",
"code": "D009123",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Faiblesse musculaire",
"alternateName": "Muscle Weakness",
"url": "https://questionsmedicales.fr/mesh/D018908",
"about": {
"@type": "MedicalCondition",
"name": "Faiblesse musculaire",
"code": {
"@type": "MedicalCode",
"code": "D018908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.593"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de la tête tombante",
"alternateName": "Dropped Head Syndrome",
"url": "https://questionsmedicales.fr/mesh/D000094222",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de la tête tombante",
"code": {
"@type": "MedicalCode",
"code": "D000094222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.593.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Amyotrophie",
"alternateName": "Muscular Atrophy",
"url": "https://questionsmedicales.fr/mesh/D009133",
"about": {
"@type": "MedicalCondition",
"name": "Amyotrophie",
"code": {
"@type": "MedicalCode",
"code": "D009133",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.612"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sarcopénie",
"alternateName": "Sarcopenia",
"url": "https://questionsmedicales.fr/mesh/D055948",
"about": {
"@type": "MedicalCondition",
"name": "Sarcopénie",
"code": {
"@type": "MedicalCode",
"code": "D055948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.612.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Myokymie",
"alternateName": "Myokymia",
"url": "https://questionsmedicales.fr/mesh/D020385",
"about": {
"@type": "MedicalCondition",
"name": "Myokymie",
"code": {
"@type": "MedicalCode",
"code": "D020385",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Myotonie",
"alternateName": "Myotonia",
"url": "https://questionsmedicales.fr/mesh/D009222",
"about": {
"@type": "MedicalCondition",
"name": "Myotonie",
"code": {
"@type": "MedicalCode",
"code": "D009222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Spasme",
"alternateName": "Spasm",
"url": "https://questionsmedicales.fr/mesh/D013035",
"about": {
"@type": "MedicalCondition",
"name": "Spasme",
"code": {
"@type": "MedicalCode",
"code": "D013035",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Spasme hémifacial",
"alternateName": "Hemifacial Spasm",
"url": "https://questionsmedicales.fr/mesh/D019569",
"about": {
"@type": "MedicalCondition",
"name": "Spasme hémifacial",
"code": {
"@type": "MedicalCode",
"code": "D019569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trismus",
"alternateName": "Trismus",
"url": "https://questionsmedicales.fr/mesh/D014313",
"about": {
"@type": "MedicalCondition",
"name": "Trismus",
"code": {
"@type": "MedicalCode",
"code": "D014313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.750.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tétanie",
"alternateName": "Tetany",
"url": "https://questionsmedicales.fr/mesh/D013746",
"about": {
"@type": "MedicalCondition",
"name": "Tétanie",
"code": {
"@type": "MedicalCode",
"code": "D013746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.608.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neuromusculaires",
"alternateName": "Neuromuscular Manifestations",
"code": {
"@type": "MedicalCode",
"code": "D020879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael S Cartwright",
"url": "https://questionsmedicales.fr/author/Michael%20S%20Cartwright",
"affiliation": {
"@type": "Organization",
"name": "Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Heinz Jungbluth",
"url": "https://questionsmedicales.fr/author/Heinz%20Jungbluth",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk."
}
},
{
"@type": "Person",
"name": "David Lacomis",
"url": "https://questionsmedicales.fr/author/David%20Lacomis",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States."
}
},
{
"@type": "Person",
"name": "Miguel A Fernandez-Garcia",
"url": "https://questionsmedicales.fr/author/Miguel%20A%20Fernandez-Garcia",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "Ruple S Laughlin",
"url": "https://questionsmedicales.fr/author/Ruple%20S%20Laughlin",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Systematic Review of Self-Report Measures of Maternal Self-Efficacy.",
"datePublished": "2022-06-17",
"url": "https://questionsmedicales.fr/article/35724766",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jogn.2022.05.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "An evaluation of the self-report instruments assessing self-control: A systematic review.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36303428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/sjop.12881"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations among claims-based care fragmentation, self-reported gaps in care coordination, and self-reported adverse events.",
"datePublished": "2024-09-10",
"url": "https://questionsmedicales.fr/article/39256705",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-11440-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inspire self report scale (ISRS): A feasibility study of a Novel self report scale for people with schizophrenia spectrum disorders.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37531843",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpsychires.2023.05.047"
}
},
{
"@type": "ScholarlyArticle",
"name": "A comparison between self-reported hand eczema and self-reported signs and symptoms of skin lesions indicating hand eczema.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35808939",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cod.14183"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Manifestations neuromusculaires",
"item": "https://questionsmedicales.fr/mesh/D020879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Manifestations neuromusculaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Manifestations neuromusculaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Manifestations neuromusculaires",
"description": "Comment diagnostiquer une myopathie ?\nQuels examens pour les neuropathies ?\nQuel rôle des tests génétiques ?\nComment évaluer la force musculaire ?\nQuand faire une IRM musculaire ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Self+Report#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Manifestations neuromusculaires",
"description": "Quels sont les symptômes d'une dystrophie musculaire ?\nComment se manifeste une neuropathie périphérique ?\nQuels signes d'une myasthénie ?\nQuels symptômes d'une sclérose latérale amyotrophique ?\nComment reconnaître un syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Self+Report#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Manifestations neuromusculaires",
"description": "Peut-on prévenir les neuropathies ?\nComment prévenir les crampes musculaires ?\nY a-t-il des mesures préventives pour la myopathie ?\nComment éviter les blessures musculaires ?\nPeut-on prévenir la sclérose latérale amyotrophique ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Self+Report#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Manifestations neuromusculaires",
"description": "Quels traitements pour la myopathie ?\nComment traiter une neuropathie diabétique ?\nQuel est le traitement de la myasthénie ?\nQuelles options pour la sclérose latérale amyotrophique ?\nComment gérer le syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Self+Report#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Manifestations neuromusculaires",
"description": "Quelles complications des myopathies ?\nQuels risques avec la neuropathie ?\nQuelles complications de la myasthénie ?\nQuels problèmes liés à la sclérose latérale amyotrophique ?\nQuelles complications du syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Self+Report#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Manifestations neuromusculaires",
"description": "Quels facteurs de risque pour les myopathies ?\nQuels risques pour la neuropathie diabétique ?\nQuels facteurs de risque pour la myasthénie ?\nQuels risques pour la sclérose latérale amyotrophique ?\nQuels facteurs de risque pour le syndrome de Guillain-Barré ?",
"url": "https://questionsmedicales.fr/mesh/D020879?mesh_terms=Self+Report#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une myopathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de myopathie nécessite un examen clinique, des tests sanguins et une biopsie musculaire."
}
},
{
"@type": "Question",
"name": "Quels examens pour les neuropathies ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les neuropathies sont diagnostiquées par électromyogramme (EMG) et études de conduction nerveuse."
}
},
{
"@type": "Question",
"name": "Quel rôle des tests génétiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests génétiques aident à identifier des maladies neuromusculaires héréditaires spécifiques."
}
},
{
"@type": "Question",
"name": "Comment évaluer la force musculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La force musculaire est évaluée par des tests de force manuelle et des échelles standardisées."
}
},
{
"@type": "Question",
"name": "Quand faire une IRM musculaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM musculaire est indiquée pour visualiser des anomalies structurelles dans les muscles."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une dystrophie musculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire progressive, crampes et difficultés à marcher."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des picotements et une perte de sensation dans les membres."
}
},
{
"@type": "Question",
"name": "Quels signes d'une myasthénie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue musculaire, ptosis (chute des paupières) et troubles de la déglutition."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une sclérose latérale amyotrophique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent faiblesse musculaire, crampes et difficultés à parler et à avaler."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un syndrome de Guillain-Barré ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se manifeste par une faiblesse musculaire rapide, des picotements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut le contrôle des maladies chroniques comme le diabète et l'évitement des toxines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crampes musculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation, l'étirement régulier et une alimentation équilibrée aident à prévenir les crampes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour la myopathie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention spécifique, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Comment éviter les blessures musculaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échauffement adéquat, des exercices appropriés et une bonne technique réduisent les blessures."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la sclérose latérale amyotrophique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de méthode prouvée pour prévenir la sclérose latérale amyotrophique."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la myopathie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des corticostéroïdes, de la physiothérapie et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Comment traiter une neuropathie diabétique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend le contrôle de la glycémie, des analgésiques et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de la myasthénie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des inhibiteurs de l'acétylcholinestérase et parfois des immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Quelles options pour la sclérose latérale amyotrophique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent des médicaments pour ralentir la progression et des soins palliatifs."
}
},
{
"@type": "Question",
"name": "Comment gérer le syndrome de Guillain-Barré ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des immunoglobulines intraveineuses et une rééducation physique."
}
},
{
"@type": "Question",
"name": "Quelles complications des myopathies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des déformations squelettiques, des problèmes respiratoires et cardiaques."
}
},
{
"@type": "Question",
"name": "Quels risques avec la neuropathie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des blessures dues à une perte de sensation et des infections cutanées."
}
},
{
"@type": "Question",
"name": "Quelles complications de la myasthénie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des crises myasthéniques, affectant la respiration et la déglutition."
}
},
{
"@type": "Question",
"name": "Quels problèmes liés à la sclérose latérale amyotrophique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les problèmes incluent la paralysie progressive, des difficultés respiratoires et des infections."
}
},
{
"@type": "Question",
"name": "Quelles complications du syndrome de Guillain-Barré ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes respiratoires, des douleurs chroniques et des séquelles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les myopathies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections virales et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels risques pour la neuropathie diabétique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète mal contrôlé, l'obésité et l'hypertension augmentent le risque de neuropathie."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la myasthénie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels risques pour la sclérose latérale amyotrophique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'âge avancé, le sexe masculin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le syndrome de Guillain-Barré ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections virales, notamment la grippe, et des antécédents de vaccination peuvent être des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Neurology Department, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Publications dans "Manifestations neuromusculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom; Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, London, United Kingdom. Electronic address: Heinz.Jungbluth@gstt.nhs.uk.
Publications dans "Manifestations neuromusculaires" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Department of Pathology (Neuropathology), University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's & St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Division of Neuromuscular Diseases, Neuropathology Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Human Performance Laboratory, Schulthess Clinic, Zurich, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Sport Sciences, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology and Neurological Sciences, Stanford University, Stanford, California.
Publications dans "Manifestations neuromusculaires" :
2 publications dans cette catégorie
Affiliations :
Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Senior Consultant and Associate Professor of Neurology, Fortis Hospital, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Dean, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India.
Publications dans "Manifestations neuromusculaires" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Publications dans "Manifestations neuromusculaires" :
To synthesize the literature to identify self-report measures used to assess maternal self-efficacy (MSE) among mothers of infants 0 to 1 year of age....
OVID (MEDLINE), CINAHL, PsycINFO, Scopus, Google Scholar....
We searched for research articles that included self-report measurement of MSE and were published from January 2000 to September 2021. We selected this time frame to focus on a contemporary context an...
We extracted measures of MSE with descriptive details, including level of self-efficacy assessed (e.g., global, domain-specific, task-specific), concept(s) assessed, reliability, eligible age ranges, ...
In many studies of MSE, researchers used measures not specifically designed for self-efficacy and instead used measures for closely related concepts such as confidence or competence. We identified onl...
We identified four instruments to measure MSE in mothers of infants, and each has strengths and weaknesses. Future researchers should focus on clear conceptual and operational alignment between MSE an...
Self-control is regarded as a necessary trait in almost every aspect of human life. Numerous self-control scales have been developed and utilized in various fields, but their psychometric characterist...
Fragmentation of care (that is, the use of multiple ambulatory providers without a dominant provider) may increase the risk of gaps in communication among providers. However, it is unclear whether peo...
We conducted a longitudinal study using data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, including a survey on perceptions of healthcare (2017-2018) and linked fe...
The correlation coefficient between claims-based and self-report was 0.37 for the number of visits and 0.38 for the number of providers (p < 0.0001 for each). Individuals with high fragmentation by cl...
Medicare beneficiaries with claims-based fragmentation also report gaps in communication among their providers. Moreover, these gaps appear to be clinically significant, with beneficiaries reporting a...
Clinician-rated symptom scales are the current standard for outcome measures in Schizophrenia Spectrum Disorders (SSD) research. There has been growing interest in the development of self-report measu...
The accuracy of self-reported hand eczema (HE) is currently unclear, and it is unknown how well self-reported signs and symptoms of skin lesions that indicate HE correlate with self-reported HE....
To correlate self-reported signs and symptoms of skin lesions on the hands with self-reported HE, to assess the sensitivity and specificity, and to suggest a definition for HE....
Seven hundred ninety-five (47.8%) of 1663 invited healthcare workers completed a digital questionnaire, and were asked to report if they experienced HE or any of the following skin signs/symptoms in p...
HE during the past 11 months was reported by 11.9%. Of these, 91.4% reported at least one skin sign versus 32.3% of those without self-reported HE. The highest sensitivity and specificity were found f...
The marked difference between self-reported HE and signs/symptoms highlights the importance of differentiating between data based on self-reported HE and signs/symptoms. As a first step towards diagno...
To investigate associations between dizziness, hearing loss, medication, and self-perceived health in the region of Lolland-Falster in Denmark....
A cross-sectional population-based study using data from questionnaires and physical examinations between February 8th, 2016, and February 13th, 2020. Individuals aged 50 years or above in the region ...
Of 10,092 individuals (52% female), the mean age was 64.7 and 65.7 years for females and males, respectively. 20% reported dizziness during the past 30 days, and prevalence increased with age. 24% of ...
One of five participants reported dizziness during the last month. Dizziness was negatively associated with self-perception of good health also after adjusting for comorbidities. Almost half of the di...
http://www....
gov (NCT02482896)....
To assess agreement for migraine day between self-report and diagnostic guidelines for children and adolescents using a headache diary....
Trial guidelines recommend prospective collection of headache features and adoption of migraine day as an outcome measure, but there is no clear consensus on the definition of migraine day....
This is a secondary analysis of data from two projects-a prospective cohort study validating a pediatric scale of treatment expectancy and a clinical trial of occipital nerve blocks to treat status mi...
Of 122 enrolled children and adolescents, 106 (86.9%) completed ≥1 detailed headache assessment (438 entries). We found moderate agreement between self-reported and ICHD-derived migraine day, with a C...
We found only moderate agreement between self-reported and ICHD-derived migraine day, suggesting both measures are not equal but may represent overlapping aspects of migraine as a disease. This highli...
Why are some people more willing than others to take risks? While behavioral tasks (e.g., monetary lotteries) are often regarded as a gold standard for capturing a person's risk preference, recent stu...
Discrimination negatively impacts health and may contribute to racial/ethnic disparities in dementia risk....
Experiences of lifetime and everyday discrimination were assessed among 6509 Multi-Ethnic Study of Atherosclerosis (MESA) participants. We assessed the association of discrimination with incidence of ...
Prevalence of any lifetime discrimination in MESA was 42%, highest among Black adults (72%). Over a median 15.7 years of follow-up, there were 466 incident cases of dementia. Lifetime discrimination, ...
These findings demonstrate an association of greater experiences of lifetime discrimination with incident dementia....
To develop a self-management instrument for organ transplant recipients that incorporates self-regulations skills and to determine its measurement properties....
The instrument includes concepts from social cognitive models: problem awareness, attitude, self-efficacy, motivation, social support, goal setting, goal pursuit, skills and goal affect. The measureme...
After face and content validity assessment 47 items were entered into the exploratory factor analysis. The analysis showed two meaningful factors, with internal consistency of 0.90 and 0.89. Spearman ...
The Self-regulation skills instrument in transplantation (SSIt) is a valid and reliable instrument to asses necessary skills for self-management after transplantation and may be useful for other patie...
Insight into self-regulation competencies can help healthcare professionals to tailor self-management support....